Clinical Intervention in Patients with IGR

ZHANG Ai-hua,LI Pei-xian,CAO Wei-hua,WEI Ai-feng
DOI: https://doi.org/10.3969/j.issn.1004-3101.2007.05.005
2007-01-01
Abstract:Objective To evaluate the influence of drug intervention and non-drug intervention in patients with impaired glucose regulation(IGR).Methods This study involved 263 patients with IGR and without renal/hepatic insufficiency in outpatients and patients in health check-up group.They were randomly divided into five groups:①diet and exercise intervention group;②flumamine intervention group:flumamine 0.25 tid;③pioglitazone intervention group:pioglitazone 15mg qd;④repaglinide intervention group:repaglinide 0.25mg tid;⑤controlled group.They were all measured FPG,2hPG,FINS,HbA1c,TC,TG,hepatic function and renal function before and after 12 months intervention.Results The incidence rate per year of diabetes:drug intervention groups are lower than non-drug intervention.groups(P<0.05).The clinical items of chemical examinations of the intervention groups are lower than controlled group(P<0.05).The decline of hazard rate of DM contrasting to the controlled group:37.3% in diet and exercise intervention group,75.3% in flumamine intervention group,74.6% in pioglitazone intervention group,84.9% in repaglinide group.Conclusion Clinical intervention in patients with IGRcan delay or prevent the occurrences of type 2 diabetes mellitus(DM) and cardiovascular complications.And drug intervention is more effective than non-drug intervention.
What problem does this paper attempt to address?